Načítá se...
Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
PURPOSE: There is no clear evidence of the benefit of adjuvant chemotherapy (AC) in stage IIA colon cancer. Therefore, we aimed to evaluate the prognostic factors and survival benefit of AC in this disease. METHODS: A retrospective data collection for patients who underwent radical surgery for colon...
Uloženo v:
| Vydáno v: | Ann Coloproctol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Society of Coloproctology
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7989565/ https://ncbi.nlm.nih.gov/pubmed/32972104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/ac.2020.09.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|